Organization
Data from Myriad Genetics offered early validation evidence for an expanded version of its commercial test, as well as a look into clinical impact via claims data.
Owner of Consulting Firm Pleads Guilty to $5.3M COVID-19 Testing Fraud Scheme
Mansinh Chaudhari purchased Medicare beneficiary information and sold it to healthcare providers who then submitted unnecessary COVID-19 tests for those beneficiaries.
T2 Biosystems Receives Delisting Notice From Nasdaq
The company has requested a hearing and paid a $20,000 fee to delay its delisting determination until Jan. 9, 2025.
In Brief This Week: Labcorp, Abbott, Danaher, MeMed, Co-Diagnostics, More
News items for the week of Dec. 9, 2024.
Through Agency-Funded Contractors, NIAID Aims to Help Bring Infectious Disease Tests to Market
Premium
The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.
Dec 2, 2024
Nov 27, 2024
Nov 27, 2024